These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27169995)

  • 1. Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.
    Huang Y; Nahar S; Nakagawa A; Fernandez-Barrena MG; Mertz JA; Bryant BM; Adams CE; Mino-Kenudson M; Von Alt KN; Chang K; Conery AR; Hatton C; Sims RJ; Fernandez-Zapico ME; Wang X; Lillemoe KD; Fernández-Del Castillo C; Warshaw AL; Thayer SP; Liss AS
    Clin Cancer Res; 2016 Aug; 22(16):4259-70. PubMed ID: 27169995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The short isoform of PRLR suppresses the pentose phosphate pathway and nucleotide synthesis through the NEK9-Hippo axis in pancreatic cancer.
    Nie H; Huang PQ; Jiang SH; Yang Q; Hu LP; Yang XM; Li J; Wang YH; Li Q; Zhang YF; Zhu L; Zhang YL; Yu Y; Xiao GG; Sun YW; Ji J; Zhang ZG
    Theranostics; 2021; 11(8):3898-3915. PubMed ID: 33664869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models of pancreatic ductal adenocarcinoma to PARP inhibitors.
    Miller AL; Fehling SC; Garcia PL; Gamblin TL; Council LN; van Waardenburg RCAM; Yang ES; Bradner JE; Yoon KJ
    EBioMedicine; 2019 Jun; 44():419-430. PubMed ID: 31126889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation.
    Martínez-Bosch N; Fernández-Barrena MG; Moreno M; Ortiz-Zapater E; Munné-Collado J; Iglesias M; André S; Gabius HJ; Hwang RF; Poirier F; Navas C; Guerra C; Fernández-Zapico ME; Navarro P
    Cancer Res; 2014 Jul; 74(13):3512-24. PubMed ID: 24812270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting BET Proteins Decreases Hyaluronidase-1 in Pancreatic Cancer.
    Kumar K; Kanojia D; Bentrem DJ; Hwang RF; Butchar JP; Tridandapani S; Munshi HG
    Cells; 2023 May; 12(11):. PubMed ID: 37296612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progression.
    Hasselluhn MC; Schmidt GE; Ellenrieder V; Johnsen SA; Hessmann E
    Cell Death Dis; 2019 Jun; 10(6):446. PubMed ID: 31171768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery.
    Li X; Truty MA; Kang Y; Chopin-Laly X; Zhang R; Roife D; Chatterjee D; Lin E; Thomas RM; Wang H; Katz MH; Fleming JB
    Clin Cancer Res; 2014 Dec; 20(24):6529-40. PubMed ID: 25336691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma.
    Song X; Chen H; Zhang C; Yu Y; Chen Z; Liang H; Van Buren G; McElhany AL; Fisher WE; Lonard DM; O'Malley BW; Wang J
    Cancer Lett; 2019 Feb; 442():310-319. PubMed ID: 30423406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycolysis and tumor progression promoted by the m
    Yang K; Zhong Z; Zou J; Liao JY; Chen S; Zhou S; Zhao Y; Li J; Yin D; Huang K; Li Y
    Cancer Lett; 2024 May; 590():216840. PubMed ID: 38604311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors.
    Roy Chaudhuri T; Lin Q; Stachowiak EK; Rosario SR; Spernyak JA; Ma WW; Stachowiak MK; Greene MK; Quinn GP; McDade SS; Clynes M; Scott CJ; Straubinger RM
    Clin Cancer Res; 2024 Apr; 30(7):1367-1381. PubMed ID: 38270582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal Adenocarcinoma.
    Chung KM; Singh J; Lawres L; Dorans KJ; Garcia C; Burkhardt DB; Robbins R; Bhutkar A; Cardone R; Zhao X; Babic A; Vayrynen SA; Dias Costa A; Nowak JA; Chang DT; Dunne RF; Hezel AF; Koong AC; Wilhelm JJ; Bellin MD; Nylander V; Gloyn AL; McCarthy MI; Kibbey RG; Krishnaswamy S; Wolpin BM; Jacks T; Fuchs CS; Muzumdar MD
    Cell; 2020 May; 181(4):832-847.e18. PubMed ID: 32304665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma.
    Fischietti M; Eckerdt F; Blyth GT; Arslan AD; Mati WM; Oku CV; Perez RE; Lee-Chang C; Kosciuczuk EM; Saleiro D; Beauchamp EM; Lesniak MS; Verzella D; Sun L; Fish EN; Yang GY; Qiang W; Platanias LC
    Oncogene; 2021 May; 40(18):3273-3286. PubMed ID: 33846574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer.
    Steele NG; Biffi G; Kemp SB; Zhang Y; Drouillard D; Syu L; Hao Y; Oni TE; Brosnan E; Elyada E; Doshi A; Hansma C; Espinoza C; Abbas A; The S; Irizarry-Negron V; Halbrook CJ; Franks NE; Hoffman MT; Brown K; Carpenter ES; Nwosu ZC; Johnson C; Lima F; Anderson MA; Park Y; Crawford HC; Lyssiotis CA; Frankel TL; Rao A; Bednar F; Dlugosz AA; Preall JB; Tuveson DA; Allen BL; Pasca di Magliano M
    Clin Cancer Res; 2021 Apr; 27(7):2023-2037. PubMed ID: 33495315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo CRISPR screening identifies geranylgeranyl diphosphate as a pancreatic cancer tumor growth dependency.
    Kubota CS; Myers SL; Seppälä TT; Burkhart RA; Espenshade PJ
    Mol Metab; 2024 Jul; 85():101964. PubMed ID: 38823776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer.
    Ligorio M; Sil S; Malagon-Lopez J; Nieman LT; Misale S; Di Pilato M; Ebright RY; Karabacak MN; Kulkarni AS; Liu A; Vincent Jordan N; Franses JW; Philipp J; Kreuzer J; Desai N; Arora KS; Rajurkar M; Horwitz E; Neyaz A; Tai E; Magnus NKC; Vo KD; Yashaswini CN; Marangoni F; Boukhali M; Fatherree JP; Damon LJ; Xega K; Desai R; Choz M; Bersani F; Langenbucher A; Thapar V; Morris R; Wellner UF; Schilling O; Lawrence MS; Liss AS; Rivera MN; Deshpande V; Benes CH; Maheswaran S; Haber DA; Fernandez-Del-Castillo C; Ferrone CR; Haas W; Aryee MJ; Ting DT
    Cell; 2019 Jun; 178(1):160-175.e27. PubMed ID: 31155233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2.
    Vogt M; Dudvarski Stankovic N; Cruz Garcia Y; Hofstetter J; Schneider K; Kuybu F; Hauck T; Adhikari B; Hamann A; Rocca Y; Grysczyk L; Martin B; Gebhardt-Wolf A; Wiegering A; Diefenbacher M; Gasteiger G; Knapp S; Saur D; Eilers M; Rosenfeldt M; Erhard F; Vos SM; Wolf E
    Gut; 2024 Aug; 73(9):1509-1528. PubMed ID: 38821858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma.
    Wang S; Xiong Y; Luo Y; Shen Y; Zhang F; Lan H; Pang Y; Wang X; Li X; Zheng X; Lu X; Liu X; Cheng Y; Wu T; Dong Y; Lu Y; Cui J; Jia X; Yang S; Wang L; Wang Y
    EMBO Mol Med; 2024 May; 16(5):1115-1142. PubMed ID: 38570712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells.
    Gailhouste L; Liew LC; Hatada I; Nakagama H; Ochiya T
    Cell Death Dis; 2018 May; 9(5):468. PubMed ID: 29700299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hedgehog acyltransferase as a target in pancreatic ductal adenocarcinoma.
    Petrova E; Matevossian A; Resh MD
    Oncogene; 2015 Jan; 34(2):263-8. PubMed ID: 24469057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I collagen deletion in αSMA
    Chen Y; Kim J; Yang S; Wang H; Wu CJ; Sugimoto H; LeBleu VS; Kalluri R
    Cancer Cell; 2021 Apr; 39(4):548-565.e6. PubMed ID: 33667385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.